Alnylam Pharmaceuticals Market Cap

Alnylam Pharmaceuticals has a market cap or net worth of 1.10 trillion as of December 5, 2025. Its market cap has increased by 80.44% in one year.

Market Cap

1.10T

Enterprise Value

1.10T

Revenue

58.88B

Ranking

n/a

PE Ratio

1,378.07

Stock Price

8,380.00

Market Cap Chart

Since May 28, 2004, Alnylam Pharmaceuticals's market cap has increased from 1.32B to 1.10T, an increase of 83,146.51%. That is a compound annual growth rate of 36.65%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	1,101.19B	74.12%
Dec 31, 2024	632.43B	55.74%
Dec 29, 2023	406.09B	-28.80%
Dec 30, 2022	570.31B	37.16%
Dec 31, 2021	415.79B	38.38%
Dec 31, 2020	300.47B	24.07%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Wal-Mart de México	1,034.78B
Grupo Financiero Banorte	490.63B
Arca Continental	313.35B
Industrias Peñoles	311.81B
GMéxico Transportes	146.17B
FIBRA Prologis	117.11B
Promotora y Operadora de Infraestructura, S. A. B. de C. V.	105.57B
Fibra UNO	100.18B

Market Cap Rankings